SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CONTOLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.086
AS - Asia 8.412
EU - Europa 4.950
SA - Sud America 1.306
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 186
OC - Oceania 32
AN - Antartide 1
Totale 30.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.721
SG - Singapore 3.281
CN - Cina 1.822
IT - Italia 1.481
BR - Brasile 1.011
VN - Vietnam 918
DE - Germania 791
HK - Hong Kong 690
UA - Ucraina 507
FI - Finlandia 471
BD - Bangladesh 457
GB - Regno Unito 397
TR - Turchia 345
FR - Francia 301
SE - Svezia 235
JP - Giappone 221
PL - Polonia 204
RU - Federazione Russa 197
ID - Indonesia 179
IN - India 164
CA - Canada 156
MX - Messico 149
AR - Argentina 121
NL - Olanda 104
ZA - Sudafrica 67
IQ - Iraq 55
PK - Pakistan 53
ES - Italia 50
EC - Ecuador 38
CO - Colombia 37
UZ - Uzbekistan 36
AT - Austria 32
BE - Belgio 32
LT - Lituania 32
PY - Paraguay 29
PH - Filippine 26
AU - Australia 25
MA - Marocco 24
CZ - Repubblica Ceca 22
VE - Venezuela 21
KR - Corea 20
MY - Malesia 19
TN - Tunisia 17
CL - Cile 16
KE - Kenya 16
PE - Perù 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
EG - Egitto 13
IE - Irlanda 12
JM - Giamaica 12
JO - Giordania 12
UY - Uruguay 12
AZ - Azerbaigian 9
CH - Svizzera 9
GT - Guatemala 9
TW - Taiwan 9
AL - Albania 8
HR - Croazia 7
HU - Ungheria 7
NI - Nicaragua 7
ET - Etiopia 6
GE - Georgia 6
KH - Cambogia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
HN - Honduras 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
LB - Libano 5
LK - Sri Lanka 5
MK - Macedonia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
CR - Costa Rica 4
EU - Europa 4
KG - Kirghizistan 4
MD - Moldavia 4
NG - Nigeria 4
BG - Bulgaria 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GY - Guiana 3
MU - Mauritius 3
SI - Slovenia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
Totale 29.935
Salva come PNG Salva come JPEG
Città #
Singapore 2.012
Ashburn 1.862
Fairfield 1.248
San Jose 1.045
Woodbridge 1.044
Houston 974
Hong Kong 678
Santa Clara 677
Jacksonville 561
Beijing 558
Chandler 537
Ann Arbor 508
Seattle 498
Wilmington 494
Cambridge 429
Munich 378
Los Angeles 312
New York 312
Ho Chi Minh City 310
Council Bluffs 299
Helsinki 280
Dallas 219
Hanoi 211
Tokyo 208
Milan 194
Warsaw 189
Ferrara 188
Izmir 187
Nanjing 179
Princeton 170
Lauterbourg 164
Jakarta 134
San Diego 106
Chicago 102
São Paulo 100
Boardman 91
Shanghai 89
Mexico City 87
Rome 87
London 69
Orem 69
Addison 64
Buffalo 63
Toronto 62
Turku 57
Atlanta 56
Dearborn 55
Frankfurt am Main 52
Nanchang 50
Da Nang 49
Shenyang 49
Tianjin 47
Bologna 46
Hefei 44
Brooklyn 42
San Francisco 42
Washington 42
The Dalles 41
Chennai 40
Mountain View 36
Montreal 35
Denver 34
Boston 32
Changsha 32
Moscow 32
Tashkent 32
Phoenix 31
Rio de Janeiro 31
Hebei 30
Nuremberg 30
Brussels 29
Haiphong 29
Jiaxing 29
Amsterdam 28
Redwood City 28
Johannesburg 27
Salt Lake City 27
Falls Church 26
Guangzhou 26
Naples 25
Columbus 24
Manchester 24
Dhaka 23
Stockholm 23
Florence 22
Jinan 22
Lappeenranta 22
Norwalk 22
Baghdad 21
Ankara 19
Bremen 19
Falkenstein 18
Istanbul 18
Mumbai 18
Orange 18
Palermo 18
Turin 18
Buenos Aires 17
Miami 17
New Delhi 17
Totale 19.789
Salva come PNG Salva come JPEG
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 517
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 440
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 360
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 345
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 325
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 314
Targeting Th2 cells in asthmatic airways 303
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 284
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 270
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 267
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 265
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 264
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 261
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 260
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 256
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 252
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 246
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 241
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 239
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 234
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 232
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 231
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 224
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 223
A serum proteome signature to predict mortality in severe COVID-19 patients 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 216
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 216
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 212
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 212
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 211
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 208
Cellule staminali e patologia polmonare dell’adulto 207
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 206
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 204
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 204
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 202
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 202
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 198
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 196
Rhinovirus vaccination: the case against 193
Models of infection and exacerbations in COPD. 191
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 191
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 191
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 186
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 186
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 185
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 184
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 184
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 183
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 183
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 182
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 181
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 179
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 179
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 178
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 177
Asthma: A Chronic Infectious Disease? 177
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 175
Disease awareness in patients with COPD: measurement and extent 174
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 174
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 170
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 169
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 168
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 167
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 166
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 166
Interactions of airway pathogens and inflammatory processes 166
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 165
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 165
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 165
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School Children 165
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 164
Pathophysiology of viral-induced exacerbations of COPD 163
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 162
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 162
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 161
The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study 160
When asthma diagnosis becomes a challenge 160
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 160
Interactions of airway pathogens and inflammatory processes 158
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 157
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 156
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 156
Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias 156
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 155
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 153
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 152
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 152
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 152
Small airway disease in asthma: pathophysiological and diagnostic considerations 151
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 151
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 150
Deficient immune response to viral infections in children predicts later Asthma persistence 150
Diffuse panbronchiolitis as parathymic syndrome in a Caucasian man previously treated for thymoma 149
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 147
Mechanisms of respiratory virus-induced asthma exacerbations 146
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 146
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 146
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life 145
Totale 20.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.565
Totale 148.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.690 100 107 363 166 530 446 208 290 833 523 596 528
2025/202612.924 1.084 493 1.032 1.460 1.910 791 1.547 748 1.214 1.266 874 505
2026/2027372 372 0 0 0 0 0 0 0 0 0 0 0
Totale 30.409